FDA and Medtech Leaders Reach MDUFA VI Commitment Agreement

Following a period of intensive negotiations between the U.S. Food and Drug Administration (FDA) and representatives from the medical device sector, a draft commitment letter for the upcoming Medical Device User Fee Amendments (MDUFA VI) program has been finalized. This MDUFA VI agreement outlines the regulatory framework for the next five fiscal years, focusing on […]

The post FDA and Medtech Leaders Reach MDUFA VI Commitment Agreement first appeared on HHM Global | B2B Online Platform & Magazine.